Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868213 · ClinicalTrials.gov registry record
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 96
- Enrollment target
NCT05868213 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 96 participants.
The verdict
NCT05868213 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of three different strains of cannabis flower one day and while not intoxicated another day. Event-related potentials (ERPs) are measured via electroencephalogram (EEG) during the recognition memory task. Blood is collected to quantify THC and CBD exposure. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Interventions
- DRUG Cannabis (smoked flower)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2024-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05868213
The ClinicalTrials.gov registry entry for NCT05868213 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis (smoked flower) is the first listed.
NCT05868213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05868213 about?
NCT05868213 is a clinical study titled "Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1". This study investigates the impact of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on recognition memory in healthy, regular cannabis users. Participants complete the same recognition memory task after self-administering one of three different strains of cannabis flower one day and while not ...
What is the current status of trial NCT05868213?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2022-08-17. Estimated completion is 2024-12-15.
What interventions are being tested in trial NCT05868213?
The interventions under investigation include: Cannabis (smoked flower) (DRUG).
Who is sponsoring clinical trial NCT05868213?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.